anti-Human p65 Antikörper für Enzyme Immunoassay

Recommended p65 Antibody (geliefert von: Anmelden zum Anzeigen )

Antigen
Nuclear Factor-KB P65 (NFkBP65) Antikörper
  • NFKB3
  • p65
  • NFkB
  • v-rel avian reticuloendotheliosis viral oncogene homolog A
  • v-rel reticuloendotheliosis viral oncogene homolog A (avian)
  • RELA
  • Rela
Epitop
pSer529
129
85
67
64
50
45
41
39
38
38
27
26
25
23
18
18
17
16
15
15
14
13
13
12
11
9
8
7
6
6
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
1169
678
521
72
56
55
30
25
25
23
13
8
8
6
4
2
1
1
Wirt
Kaninchen
1008
140
25
11
1
1
Klonalität
Polyklonal
Konjugat
Dieser p65 Antikörper ist unkonjugiert
30
28
22
21
20
19
16
14
14
14
13
10
10
8
8
8
8
8
8
4
4
3
3
3
2
2
2
2
2
2
1
Applikation
Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
844
443
324
259
207
162
107
105
89
28
18
18
15
12
12
8
6
6
5
5
4
2
2
2
1
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Request

Produkt kostenlos erhalten?

Für Ihre Validierungsdaten erstatten wir Ihnen den vollen Kaufpreis. Ich möchte dieses Produkt validieren

Mehr erfahren

Produktnummer ABIN5556647
$ 411.18
Zzgl. Versandkosten $45.00
Relevance Score ABIN Application Konjugat Host Isotype Epitope Hersteller Clonality References Details
1 ABIN5556664 EMSA EIA IF WB Rabbit N-Term, NLS Domain Anmelden zum Anzeigen Polyclonal
1 ABIN5551725 EIA IHC (p) WB Rabbit IgG Ser536 Anmelden zum Anzeigen Polyclonal
1 ABIN5551724 EIA IHC (p) WB Rabbit IgG pSer276 Anmelden zum Anzeigen Polyclonal
1 ABIN318869 EIA IHC (p) WB Rabbit IgG Ser536 Anmelden zum Anzeigen Polyclonal 1
1 ABIN5556626 EMSA EIA IP WB Rabbit C-Term Anmelden zum Anzeigen Polyclonal
1 ABIN303222 EIA IHC (p) WB Rabbit Ser536 Anmelden zum Anzeigen Polyclonal
1 ABIN271750 EIA IHC (p) WB Rabbit Anmelden zum Anzeigen Polyclonal
1 ABIN303336 EIA IHC (p) IP WB Rabbit pSer529 Anmelden zum Anzeigen Polyclonal
1 ABIN318086 EIA IHC (p) IP WB Rabbit pThr254 Anmelden zum Anzeigen Polyclonal
1 ABIN303337 EIA IF IHC (p) IP WB Rabbit C-Term Anmelden zum Anzeigen Polyclonal
1 ABIN121827 EMSA EIA IP WB Sheep AA 12-317 Anmelden zum Anzeigen Polyclonal
1 ABIN121887 EMSA EIA IHC (fro) IP WB Rabbit C-Term Anmelden zum Anzeigen Polyclonal
1 ABIN117925 EMSA EIA IP WB Rabbit N-Term Anmelden zum Anzeigen Polyclonal
1 ABIN1108855 EIA WB Mouse IgG1 Anmelden zum Anzeigen 6H7
1 ABIN5541899 EIA Rabbit pSer276 Anmelden zum Anzeigen Polyclonal
1 ABIN5541898 EIA Rabbit pSer468 Anmelden zum Anzeigen Polyclonal
1 ABIN5541897 EIA Rabbit pSer468 Anmelden zum Anzeigen Polyclonal
1 ABIN5541900 EIA Rabbit pSer276 Anmelden zum Anzeigen Polyclonal

General

Antigen Nuclear Factor-KB P65 (NFkBP65) Antikörper
Epitop pSer529
(129), (85), (67), (64), (50), (45), (41), (39), (38), (38), (27), (26), (25), (23), (18), (18), (17), (16), (15), (15), (14), (13), (13), (12), (11), (9), (8), (7), (6), (6), (4), (4), (4), (4), (4), (4), (4), (4), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reaktivität Human
(1169), (678), (521), (72), (56), (55), (30), (25), (25), (23), (13), (8), (8), (6), (4), (2), (1), (1)
Wirt Kaninchen
(1008), (140), (25), (11), (1), (1)
Klonalität
Polyklonal
Konjugat Dieser p65 Antikörper ist unkonjugiert
(30), (28), (22), (21), (20), (19), (16), (14), (14), (14), (13), (10), (10), (8), (8), (8), (8), (8), (8), (4), (4), (3), (3), (3), (2), (2), (2), (2), (2), (2), (1)
Applikation Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
(844), (443), (324), (259), (207), (162), (107), (105), (89), (28), (18), (18), (15), (12), (12), (8), (6), (6), (5), (5), (4), (2), (2), (2), (1)
Hersteller Anmelden zum Anzeigen

Produktdetails anti-p65 Antikörper

Target Details p65 Anwendungsinformationen Handhabung Bilder
Sequenz PNGLLpSGDE DFC
Spezifität This phospho-specific polyclonal antibody is specific for phosphorylated pSer529 Human p65. Reactivity with non-phosphorylated p65 is minimal. Cross reactivity with pSer529 phosphorylated p65 from Mouse, Rat or other species has not been determined. Anti-phospho NFkB antibody reacts human pS529 p65 and shows minimal reactivity by Western blot with non-phosphorylated p65 and minimal reactivity by ELISA against the non-phosphorylated form of the immunizing peptide.
Produktmerkmale Concentration: 75.0 mg/mL (by Refractometry)
Reinigung Delipidation and Defibrination
Immunogen NFkB p65 (Rel A) peptide corresponding to a region near phospho Serine 529 of the Human protein conjugated to Keyhole Limpet Hemocyanin (KLH). Sequence information: PNGLLpSGDEDFC

Target Details p65

Produktdetails anti-p65 Antikörper Anwendungsinformationen Handhabung Bilder zurück nach oben
Antigen
Andere Bezeichnung RELA / NF-kB p65 (NFkBP65 Antibody Abstract)
Hintergrund NFkB (Nuclear Factor NF-kappa-B) is a pleiotropic transcription factor that plays a role in many biological processes, including inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis. It is found as a homo- or heterodimeric complex containing the Rel-like domain containing proteins NFkB p65 (RELA/p65), RELB, NFkB1/p105, NFkB1/p50, REL and NFkB2/p52. The heterodimeric NFkB p65/p50 complex is the most abundant one. The dimers bind to kappa-B sites at their target genes, with the affinity of the interaction dependent on the subunit composition of the dimer. Furthermore, different dimers act as transcriptional activators or repressors, with the NFkB p65/p50 and p65-c-Rel complexes acting as activators. NFkB activity is controlled by several different mechanisms, including post-translational modifications, subcellular localisation and interactions with other coactivators or corepressors. NFkB complexes are held in the cytoplasm in an inactive state by interaction with members of the NFkB inhibitor (IkB) family. Typically, phosphorylation of IkB by IkB kinases (IKKs) in response to different activators leads to degradation of the inhibitor, allowing NFkB to translocate into the nucleus. The inhibitory effect of IkBs is primarily exerted through their interaction with NfKB p65. NFkB p65 is ubiquitinated leading to its proteosomal degradation, which is required for termination of the NFkB response. Phosphorylation of NFkB p65 on S536 stimulates acetylation of K310 by CBP, enhancing transcriptional activity. NFkB p65 is also acetylated at K122, enhancing DNA binding and impairing the interaction with NFKBIA. The protein is deacetylated by HDAC3. Invasion of a host by a pathogen is frequently associated with the activation of NF-kB, which coordinates various aspects of immune function required for resistance to infection.Synonyms: NF kappa B p65, NFKB3, NFkB p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, Rel A, Transcription factor p65
Gen-ID 5970
NCBI Accession NP_001138610
UniProt Q04206
Pathways NF-kappaB Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades

Anwendungsinformationen

Produktdetails anti-p65 Antikörper Target Details p65 Handhabung Bilder zurück nach oben
Applikationshinweise For immunoblotting a 1: 1,000 dilution is recommended. A 65 kDa band corresponding to human p65 is detected. HeLa cells or TNF inducible KBM-5cells can be used as a positive control. For ELISA a 1: 5,000 to 1: 10,000 dilution is recommended. Researchers should determineoptimal titers for other applications. Although not tested, this antibody is likely functional in immunohistochemistry andimmunoprecipitation.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen Nur für Forschungszwecke einsetzbar

Handhabung

Produktdetails anti-p65 Antikörper Target Details p65 Anwendungsinformationen Bilder zurück nach oben
Format Liquid
Konzentration 75.0 mg/mL
Buffer 0.09 % (w/v) Sodium Azide
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung Avoid repeated freezing and thawing.
Lagerung 4 °C/-20 °C
Informationen zur Lagerung Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.